Who owns Neurocrine Biosciences?

Key details on Neurocrine Biosciences (Ticker: NBIX)

Who owns Neurocrine Biosciences?

Is NBIX a good stock to own? Find out who bought Neurocrine Biosciences, who sold Neurocrine Biosciences (NBIX) stock, and who holds a large position in Neurocrine Biosciences.

Fund Name Number of Shares Share Valuation As Of
FMR 10.10M $94.35M Dec. 31, 2013
T. Rowe Price Associates 9.31M $86.97M Dec. 31, 2013
BVF 5.93M $50.40M Dec. 31, 2011
Perceptive Advisors 4.18M $39.08M Dec. 31, 2013
STATE STREET CORPORATION 2.75M $25.67M Dec. 31, 2013
BB Biotech AG 2.65M $24.72M Dec. 31, 2013
OrbiMed Advisors 2.63M $24.57M Dec. 31, 2013
BlackRock Fund Advisors 2.41M $22.55M Dec. 31, 2013
Visium Asset Management 2.11M $19.73M Dec. 31, 2013
Franklin Resources 2.10M $19.60M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 1.94M $18.12M Dec. 31, 2013
Vanguard 1.89M $17.62M Dec. 31, 2013
S.A.C. Capital Advisors 1.88M $14.07M Dec. 31, 2012
Jennison Associates 1.64M $18.59M Sept. 30, 2013
Turner Investments 1.27M $14.39M Sept. 30, 2013
VHCP Management 1.27M $14.39M Sept. 30, 2013
PointState Capital 1.12M $15.05M June 30, 2013
Loomis, Sayles and 1.12M $14.99M June 30, 2013
Deutsche Bank Aktiengesellschaft 1.06M $9.68M Dec. 31, 2013
Meditor 1.05M $11.89M Sept. 30, 2013
Janus Capital Management 1.00M $11.34M Sept. 30, 2013
NORTHERN TRUST 969752 $9.06M Dec. 31, 2013
Hambrecht & Quist Capital Management 943987 $11.46M March 31, 2013
Wellington Management Company 941103 $7.04M Dec. 31, 2012

Who sold Neurocrine Biosciences?

Fund Name Date Sold Number of Shares Sold Share Valuation
Inves June 30, 2011 1.04M $8.41M